Vivimed Labs obtains PIC/S GMP approval for its Hyderabad manufacturing facility

Vivimed Labs has received the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/s) Good Manufacturing Practices (GMP) approval for its pharmaceutical manufacturing facility in Jeedimetla, Hyderabad. The company has received GMP approval for the supply of finished dosage formulations to the Common wealth of Independent States (CIS) region.

Vivimed and its wholly-owned subsidiaries also have three US FDA/EDQM approved API facilities in Spain and Mexico, and one US FDA approved finished formulation facility in India. The PIC/S are two international instruments between countries and pharmaceutical inspection authorities, which provide together an active and constructive co-operation in the field of GMP. PIC/S's mission is to lead the international development, implementation and maintenance of harmonized Good Manufacturing Practice (GMP) standards and quality systems of inspectorates in the field of medicinal products.

This approval provides company with a significant opportunity to penetrate the CIS markets and other PIC/S member countries for the formulation manufacturing business. According to company’s spokesperson the PIC/S GMP approval is a testament to the quality of our manufacturing facilities and commitment to match the international regulatory expectations of the pharmaceutical business. It will provide Vivimed with an opportunity to start catering to customers in the CIS region and other Asian countries. The company is confident that this will help in enhancing its formulations exports business.